415 related articles for article (PubMed ID: 32963090)
21. Clinical Characteristics and Outcomes of Community- and Hospital-Acquired Acute Kidney Injury with COVID-19 in a US Inner City Hospital System.
Pelayo J; Lo KB; Bhargav R; Gul F; Peterson E; DeJoy Iii R; Salacup GF; Albano J; Gopalakrishnan A; Azmaiparashvili Z; Patarroyo-Aponte G; Rangaswami J
Cardiorenal Med; 2020; 10(4):223-231. PubMed ID: 32554965
[TBL] [Abstract][Full Text] [Related]
22. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis.
Hansrivijit P; Qian C; Boonpheng B; Thongprayoon C; Vallabhajosyula S; Cheungpasitporn W; Ghahramani N
J Investig Med; 2020 Oct; 68(7):1261-1270. PubMed ID: 32655013
[TBL] [Abstract][Full Text] [Related]
23. Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department.
Stauning MA; Altintas I; Kallemose T; Eugen-Olsen J; Lindstrøm MB; Rasmussen LJH; Gamst-Jensen H; Nehlin JO; Andersen O; Tingleff J
J Emerg Med; 2021 Sep; 61(3):298-313. PubMed ID: 34092446
[TBL] [Abstract][Full Text] [Related]
24. Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia.
Pei G; Zhang Z; Peng J; Liu L; Zhang C; Yu C; Ma Z; Huang Y; Liu W; Yao Y; Zeng R; Xu G
J Am Soc Nephrol; 2020 Jun; 31(6):1157-1165. PubMed ID: 32345702
[TBL] [Abstract][Full Text] [Related]
25. [Clinical characteristics and risk factors of acute kidney injury in coronavirus disease 2019].
Zhang J; Li J; Su L; Yang J; Jiang X; Jiang N; Lei Y; He L; Lu Q; Shen S; Chen F; Peng Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):407-411. PubMed ID: 32527342
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Kidney Injury and Associations with Critical Illness and Death in Patients with COVID-19.
Zheng X; Yang H; Li X; Li H; Xu L; Yu Q; Dong Y; Zhao Y; Wang J; Hou W; Zhang X; Li Y; Hu F; Gao H; Lv J; Yang L
Clin J Am Soc Nephrol; 2020 Nov; 15(11):1549-1556. PubMed ID: 32943396
[TBL] [Abstract][Full Text] [Related]
27. An open label trial of anakinra to prevent respiratory failure in COVID-19.
Kyriazopoulou E; Panagopoulos P; Metallidis S; Dalekos GN; Poulakou G; Gatselis N; Karakike E; Saridaki M; Loli G; Stefos A; Prasianaki D; Georgiadou S; Tsachouridou O; Petrakis V; Tsiakos K; Kosmidou M; Lygoura V; Dareioti M; Milionis H; Papanikolaou IC; Akinosoglou K; Myrodia DM; Gravvani A; Stamou A; Gkavogianni T; Katrini K; Marantos T; Trontzas IP; Syrigos K; Chatzis L; Chatzis S; Vechlidis N; Avgoustou C; Chalvatzis S; Kyprianou M; van der Meer JW; Eugen-Olsen J; Netea MG; Giamarellos-Bourboulis EJ
Elife; 2021 Mar; 10():. PubMed ID: 33682678
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts.
Lablad Y; Vanhomwegen C; De Prez E; Antoine MH; Hasan S; Baudoux T; Nortier J
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003685
[TBL] [Abstract][Full Text] [Related]
29. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
[TBL] [Abstract][Full Text] [Related]
30. Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study.
Cui X; Yu X; Wu X; Huang L; Tian Y; Huang X; Zhang Z; Cheng Z; Guo Q; Zhang Y; Cai Y; Zhan Q
Kidney Blood Press Res; 2020; 45(4):612-622. PubMed ID: 32712607
[TBL] [Abstract][Full Text] [Related]
31. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.
Wang L; Li X; Chen H; Yan S; Li D; Li Y; Gong Z
Am J Nephrol; 2020; 51(5):343-348. PubMed ID: 32229732
[TBL] [Abstract][Full Text] [Related]
32. Acute kidney injury in critically ill patients with COVID-19.
Gabarre P; Dumas G; Dupont T; Darmon M; Azoulay E; Zafrani L
Intensive Care Med; 2020 Jul; 46(7):1339-1348. PubMed ID: 32533197
[TBL] [Abstract][Full Text] [Related]
33. Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.
Samman Tahhan A; Hayek SS; Sandesara P; Hajjari J; Hammadah M; O'Neal WT; Kelli HM; Alkhoder A; Ghasemzadeh N; Ko YA; Aida H; Gafeer MM; Abdelhadi N; Mohammed KH; Patel K; Arya S; Reiser J; Vaccarino V; Sperling L; Quyyumi A
Atherosclerosis; 2017 Sep; 264():108-114. PubMed ID: 28728756
[TBL] [Abstract][Full Text] [Related]
34. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis.
Lin L; Wang X; Ren J; Sun Y; Yu R; Li K; Zheng L; Yang J
BMJ Open; 2020 Nov; 10(11):e042573. PubMed ID: 33172950
[TBL] [Abstract][Full Text] [Related]
35. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
[TBL] [Abstract][Full Text] [Related]
36. Correlation of biomarkers for parasite burden and immune activation with acute kidney injury in severe falciparum malaria.
Plewes K; Royakkers AA; Hanson J; Hasan MM; Alam S; Ghose A; Maude RJ; Stassen PM; Charunwatthana P; Lee SJ; Turner GD; Dondorp AM; Schultz MJ
Malar J; 2014 Mar; 13():91. PubMed ID: 24618154
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive review and meta-analysis of suPAR as a predictor of acute kidney injury.
Jankowski L; Pruc M; Gasecka A; Chmielewski J; Wojcik T; Szarpak L; Kowalczyk M
Ann Agric Environ Med; 2023 Jun; 30(2):364-368. PubMed ID: 37387388
[TBL] [Abstract][Full Text] [Related]
38. Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysis.
Matuszewski M; Ładny J; Rafique Z; Peacock F; Pruc M; Gasecka A; Szwed P; Jankowski L; Chmielewski J; Panasiuk L; Szarpak L
Ann Agric Environ Med; 2023 Mar; 30(1):142-147. PubMed ID: 36999867
[TBL] [Abstract][Full Text] [Related]
39. Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients.
Chalkias A; Mouzarou A; Samara E; Xanthos T; Ischaki E; Pantazopoulos I
Mol Diagn Ther; 2020 Oct; 24(5):517-521. PubMed ID: 32613288
[TBL] [Abstract][Full Text] [Related]
40. The Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.
Qin Y; Qiao Y; Wang D; Yan G; Tang C; Ma G
Int J Gen Med; 2021; 14():6497-6504. PubMed ID: 34675617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
